Guo-Ping Shi Selected Research

ketotifen fumarate ophthalmic solution (Zaditor)

11/2011

Mast cell stabilization: novel medication for obesity and diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guo-Ping Shi Research Topics

Disease

42	Atherosclerosis 01/2020 - 03/2003
35	Abdominal Aortic Aneurysm 01/2022 - 02/2006
24	Inflammation (Inflammations) 01/2022 - 02/2006
18	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 03/2003
13	Fibrosis (Cirrhosis) 01/2022 - 08/2008
12	Obesity 01/2020 - 12/2008
10	Body Weight (Weight, Body) 01/2020 - 08/2007
10	Myocardial Infarction 01/2019 - 06/2006
8	Neoplasms (Cancer) 01/2022 - 03/2006
6	Hypertension (High Blood Pressure) 01/2022 - 11/2006
6	Insulin Resistance 01/2022 - 10/2012
6	Vascular Remodeling 01/2021 - 01/2004
6	Atherosclerotic Plaque (Atheroma) 01/2020 - 02/2005
5	Cardiomegaly (Heart Hypertrophy) 04/2022 - 02/2013
5	Glucose Intolerance 01/2022 - 08/2007
5	Coronary Disease (Coronary Heart Disease) 12/2020 - 02/2009
5	Hyperplasia 01/2020 - 01/2016
5	Aneurysm (Aneurysms) 01/2020 - 11/2006
5	Heart Failure 01/2018 - 11/2006
5	Vascular Diseases (Vascular Disease) 11/2014 - 02/2006
4	Hypertrophy 04/2022 - 11/2006
4	Hypoxia (Hypoxemia) 12/2020 - 07/2010
4	Asthma (Bronchial Asthma) 01/2020 - 01/2016
4	Pneumonia (Pneumonitis) 11/2019 - 01/2016
4	Infarction (Infarctions) 08/2019 - 01/2012
4	Disease Progression 01/2018 - 04/2009
4	Rupture 03/2016 - 06/2011
3	Aortic Aneurysm (Aneurysm, Aortic) 01/2022 - 11/2006
3	Neointima 12/2019 - 01/2004
3	Ischemia 11/2019 - 08/2010
3	Ventricular Remodeling 01/2019 - 10/2014
3	Peripheral Arterial Disease 12/2018 - 01/2012
3	Rheumatoid Arthritis 01/2018 - 05/2011
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 01/2017
3	Infections 08/2017 - 12/2008
3	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 06/2009
3	Pathologic Constriction (Stenosis) 11/2011 - 02/2006
3	Unstable Angina 09/2011 - 06/2006
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 11/2015
2	Hyperglycemia 01/2022 - 12/2011
2	COVID-19 12/2021 - 01/2020
2	Necrosis 12/2021 - 01/2021
2	Chronic Renal Insufficiency 08/2021 - 04/2009
2	Colitis 01/2021 - 11/2019
2	Frailty 02/2020 - 05/2018
2	Ureteral Obstruction 11/2019 - 09/2019
2	Chronic Obstructive Pulmonary Disease (COPD) 11/2019 - 12/2018

Drug/Important Bio-Agent (IBA)

24	CathepsinsIBA 01/2020 - 01/2004
22	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2004
21	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 03/2003
18	Cysteine Proteases (Cysteine Protease)IBA 01/2018 - 01/2004
16	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2006
16	cathepsin SIBA 11/2019 - 03/2003
15	Cathepsin KIBA 01/2022 - 03/2007
15	Apolipoproteins E (ApoE)IBA 01/2020 - 02/2005
12	Immunoglobulin E (IgE)IBA 01/2020 - 01/2011
12	CytokinesIBA 11/2019 - 03/2003
11	Angiotensin IIIBA 01/2021 - 03/2010
10	ApolipoproteinsIBA 12/2017 - 02/2005
10	Cystatin CIBA 02/2014 - 03/2003
9	Biomarkers (Surrogate Marker)IBA 02/2020 - 06/2006
9	ElastinIBA 05/2016 - 01/2004
8	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 08/2004
8	LDL Receptors (LDL Receptor)IBA 11/2014 - 03/2003
7	Cathepsin LIBA 01/2020 - 02/2006
7	CholesterolIBA 01/2020 - 03/2003
7	Chymases (Chymase)IBA 01/2019 - 09/2009
7	Tryptases (Tryptase)IBA 01/2013 - 01/2011
6	CollagenIBA 01/2021 - 04/2007
5	LipidsIBA 01/2020 - 02/2005
5	Insulin (Novolin)FDA Link 02/2013 - 03/2006
4	Toll-Like Receptor 2IBA 01/2022 - 03/2014
4	ChemokinesIBA 01/2020 - 08/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2019 - 03/2006
4	InterleukinsIBA 01/2018 - 06/2007
4	Interleukin-6 (Interleukin 6)IBA 12/2017 - 06/2007
4	Protease Inhibitors (Protease Inhibitor)IBA 01/2013 - 02/2005
4	Pancreatic Elastase (Elastase)IBA 01/2012 - 11/2007
4	EnzymesIBA 09/2011 - 08/2004
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2021 - 03/2011
3	Pharmaceutical PreparationsIBA 01/2021 - 09/2005
3	Interleukin-18 (Interleukin 18)IBA 01/2020 - 07/2015
3	Complement System Proteins (Complement)IBA 01/2017 - 02/2009
3	Serine Proteases (Serine Protease)IBA 12/2015 - 08/2004
3	Interleukin-17 (Interleukin 17)IBA 10/2014 - 06/2009
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2011 - 02/2006
3	SaltsIBA 03/2011 - 07/2009
2	Interleukin-4 (Interleukin 4)IBA 04/2022 - 12/2020
2	Interleukin-13IBA 04/2022 - 01/2016
2	Streptozocin (Streptozotocin)FDA Link 01/2022 - 01/2019
2	Caspase 8 (Caspase-8)IBA 01/2022 - 12/2019
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 11/2015
2	Collagen Type I (Type I Collagen)IBA 01/2022 - 01/2019
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2021 - 12/2018
2	CreatinineIBA 08/2021 - 06/2006
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 11/2014
2	HDL LipoproteinsIBA 01/2020 - 11/2014
2	anti-IgE antibodiesIBA 01/2019 - 01/2016

Therapy/Procedure

10	Therapeutics 01/2022 - 04/2009
3	Ligation 01/2018 - 03/2014